Last $0.99 USD
Change Today -0.02 / -1.98%
Volume 20.5K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$1.00
Previous Close
$1.01
Day High
$1.00
Day Low
$0.99
52 Week High
07/5/13 - $1.30
52 Week Low
02/13/14 - $0.72
Market Cap
61.2M
Average Volume 10 Days
236.5K
EPS TTM
$-0.37
Shares Outstanding
61.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States, India, France, Iraq, and China. Its products include Quantum Sniffer a QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 benchtop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. The company offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. Implant Sciences Corporation markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. The company was founded in 1984 and is headquartered in Wilmington, Massachusetts.

65 Employees
Last Reported Date: 09/30/13
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $220.0K
Chief Operating Officer and Director
Total Annual Compensation: $250.0K
Vice President of Technology
Total Annual Compensation: $190.0K
Vice President of Manufacturing Operations
Total Annual Compensation: $235.0K
Compensation as of Fiscal Year 2013.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corporation Elects John Hassett to the Board of Directors

Implant Sciences Corporation announced that John Hassett has been elected to the company's Board of Directors. Mr. Hassett is currently Managing Principal and President of Little Harbor Advisors LLC. He has over 12 years' experience in the investment management business. Mr. Hassett becomes Implant Sciences' seventh director. Mr. Hassett is a serial entrepreneur and inventor who has built and sold several high-tech startups including Multilink, AT/Comm and Vialog.

Implant Sciences Corporation Receives Product Approval in Germany for QS-B220 Explosives Trace Detector

Implant Sciences Corporation announced that its QS-B220 desktop explosives trace detector has received regulatory approval from the German Federal Ministry of the Interior for aviation security applications at German airports. The QS-B220 fulfills specifications set by the German Federal Police. With the German Federal Ministry of the Interior approval, the QS-B220 may now be deployed at all non-passenger airport checkpoints for screening of deliveries, food service, and other airport service functions. Testing and evaluation was conducted at the German National Test Center for the Evaluation of Explosives Detection Systems, established by the German Federal Police, in conjunction with the Fraunhofer Institute for Chemical Technology. The realistic testing environment provided by the Center is essential for security services and end users such as airport operators to obtain reliable performance data and ensure a uniform security standard throughout Europe.

Implant Sciences Corporation Completes $20,000,000 Refinancing

Implant Sciences Corporation announced the execution of a Note Purchase Agreement with an accredited institutional investor group, on March 19, 2014. The company issued senior secured promissory notes in the principal amount of $20,000,000 to this investor group. Implant Sciences used the proceeds of the loan to pay down its DMRJ Group LLC line of credit as well as some portions of its other indebtedness to DMRJ. The new notes mature on March 31, 2015, are not convertible in shares of the company's common stock and bear interest at 15% per annum, payable quarterly. The loan may be prepaid by Implant Sciences on 30 days' notice, without premium or penalty. The new loans, which are senior to the DMRJ debt, are secured by the assets of the Company and its subsidiaries. In addition to this refinancing, DMRJ has agreed to extend the maturity of all Implant Sciences' indebtedness from September 30, 2014 to March 31, 2015 and has agreed to subordinate its position to the new lenders. No other terms or conditions of the DMRJ credit agreements were changed.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.99 USD -0.02

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMSC.
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.